论文部分内容阅读
<正>Objective To evaluate the efficacy and safety of the combination of XELOX regimen(oxaliplatin plus capecitabine) with thalidomide for the first-line treatment of metastatic colorectal cancer(MCRC). Methods All of the 89 patients with MCRC who ful